Philippe de Moerloose

12.5k total citations · 1 hit paper
220 papers, 8.2k citations indexed

About

Philippe de Moerloose is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Philippe de Moerloose has authored 220 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 60 papers in Pulmonary and Respiratory Medicine and 49 papers in Internal Medicine. Recurrent topics in Philippe de Moerloose's work include Blood properties and coagulation (55 papers), Venous Thromboembolism Diagnosis and Management (49 papers) and Blood Coagulation and Thrombosis Mechanisms (45 papers). Philippe de Moerloose is often cited by papers focused on Blood properties and coagulation (55 papers), Venous Thromboembolism Diagnosis and Management (49 papers) and Blood Coagulation and Thrombosis Mechanisms (45 papers). Philippe de Moerloose collaborates with scholars based in Switzerland, France and United States. Philippe de Moerloose's co-authors include Marguerite Neerman‐Arbez, Guido Reber, Alessandro Casini, Françoise Boehlen, Henri Bounameaux, Jean‐François Hardy, Arnaud Perrier, Toshihide Kobayashi, Jean Grüenberg and Robert G. Parton and has published in prestigious journals such as Nature, The Lancet and Circulation.

In The Last Decade

Philippe de Moerloose

215 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A lipid associated with the antiphospholipid syndrome regulates endosome structure and function

1998 670 citations Philippe de Moerloose et al. profile →

Peers

Countries citing papers authored by Philippe de Moerloose

Since Specialization

Citations

This map shows the geographic impact of Philippe de Moerloose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe de Moerloose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe de Moerloose more than expected).

Fields of papers citing papers by Philippe de Moerloose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe de Moerloose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe de Moerloose. The network helps show where Philippe de Moerloose may publish in the future.

Co-authorship network of co-authors of Philippe de Moerloose

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe de Moerloose. A scholar is included among the top collaborators of Philippe de Moerloose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe de Moerloose. Philippe de Moerloose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, development and usability of an educational AI chatbot for People with Haemophilia in Senegal 2023 ·Haemophilia ·(unknown), Philippe de Moerloose, Saliou Diop, Antoine Geissbühler	12
2	High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia 2022 ·Haemophilia ·(unknown), Philippe de Moerloose, Alessandro Casini	3
3	New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia 2021 ·Thrombosis and Haemostasis ·Jan Astermark, Cihan Ay, Manuela Carvalho, Roseline d’Oiron, Philippe de Moerloose, Gerard Dolan, Pierre Fontana, Cédric Hermans, Pål André Holme, Όλγα Κατσαρού, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, (unknown), Ramiro Núñez, Ingrid Pabinger, Robert C. Tait, Paul van der Valk	0
4	Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia 2021 ·Blood ·Alessandro Casini, Sylvia von Mackensen, Cristina Santoro, Claudia Djambas Khayat, (unknown), Cecil Ross, Akbar Dorgalaleh, Arshi Naz, Ekrem Ünal, (unknown), Elise Dupuis‐Lozeron, Nathalie Trillot, Sophie Susen, Flora Peyvandi, Philippe de Moerloose	24
5	How I treat dysfibrinogenemia 2021 ·Blood ·Alessandro Casini, Philippe de Moerloose	26
6	A survey among patients with haemophilia and inhibitors or their caregivers, seeking treatment in non‐haemophilia treatment centres 2020 ·Haemophilia ·Joanna A. Davis, Robert Klamroth, (unknown), (unknown), Philippe de Moerloose	1
7	Barriers and challenges for the fast treatment of bleeds in the non‐haemophilia treatment centre hospital setting 2020 ·Haemophilia ·Philippe de Moerloose, Joanna A. Davis, (unknown), (unknown), Robert Klamroth	3
8	The impact of haemophilia on the social status and the health‐related quality of life in adult Lebanese persons with haemophilia 2019 ·Haemophilia ·(unknown), Philippe de Moerloose, Ghassan Sleilaty, Alessandro Casini, Claudia Djambas Khayat	8
9	Fibrinogen concentrates in hereditary fibrinogen disorders: Past, present and future 2019 ·Haemophilia ·Alessandro Casini, Philippe de Moerloose	25
10	Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia 2017 ·Haemophilia ·Alessandro Casini, R. Vilar, (unknown), Deniz Aslan, Katrien Devreese, Veerle Mondelaers, Lorenzo Alberio, (unknown), Philippe de Moerloose, Marguerite Neerman‐Arbez	14
11	Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization 2017 ·Haemophilia ·(unknown), (unknown), (unknown), (unknown), (unknown), Taïeb Messaoud, Mohamed Tahar Sfar, Alessandro Casini, Philippe de Moerloose, (unknown)	7
12	Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications 2016 ·Clinica Chimica Acta ·(unknown), Choumous Kallel, (unknown), (unknown), Moez Elloumi, (unknown), (unknown), Taïeb Messaoud, Philippe de Moerloose, (unknown)	5
13	TLR2 Ligands Induce NF-κB Activation from Endosomal Compartments of Human Monocytes 2013 ·PLoS ONE ·Karim J. Brandt, Céline Fickentscher, Egbert K. O. Kruithof, Philippe de Moerloose	65
14	Antiplatelet Drug Response Status Does Not Predict Recurrent Ischemic Events in Stable Cardiovascular Patients 2012 ·Circulation ·Jean‐Luc Reny, Philippe Berdagué, Antoine Poncet, I. Barazer, Séverine Nolli, Pascale Fabbro-Péray, Jean‐François Schved, Henri Bounameaux, François Mach, Philippe de Moerloose, Pierre Fontana	66
15	Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data 2007 ·Haemophilia ·Michael Richards, Carmen Altisent, Angelika Bátorová, Hérvè Chambost, G. Dolan, Philippe de Moerloose, Máximo Fraga, Cédric Hermans, Anastasia Karafoulidou, Robert Klamroth, Riitta Lassila, C. Rothschild, (unknown)	54
16	Fibrin D-Dimer Testing for Venous and Arterial Thrombotic Disease 2005 ·Seminars in Vascular Medicine ·Jan Michiels, Gualtiero Palareti, Philippe de Moerloose	8
17	Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia. 2000 ·Blood ·Marguerite Neerman‐Arbez, Philippe de Moerloose, Claire Bridel, (unknown), (unknown), Colette Rossier, Kathelijne Peerlinck, S. Claeyssens, (unknown), Roseline d’Oiron, Marie Dreyfus, (unknown), (unknown), Stylianos E. Antonarakis, Michael A. Morris	77
18	D-Dimer Assays for the Exclusion of Venous Thromboembolism 2000 ·Seminars in Thrombosis and Hemostasis ·Guido Reber, Philippe de Moerloose	26
19	Traitement anticoagulant et éducation du patient : une nécessité 1999 ·Sang thrombose vaisseaux ·Philippe de Moerloose, B Boneu	6
20	D-dimères et diagnostic d'exclusion de la maladie thromboembolique veineuse 1996 ·Hématologie ·Guido Reber, (unknown), Philippe de Moerloose	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact